EudraVigilance lists more than 2 million reports of adverse reactions after Covid vaccination
The European database EudraVigilance now lists 2,247,201 adverse reaction cases reported after the administration of Covid vaccines in Europe. The data is up to June 23, 2023.
There was an unexpected update to the statistics on Friday.
The EudraVigilance data is now usually updated on Mondays and there was an update on June 19, but statistics relating to the Janssen Biotech vaccine were not included. The European Medicines Agency said that data related to the Janssen vaccine, now branded in Europe as Jcovden, was temporarily unavailable “due to technical issues”.
The Janssen data is present in the latest update.
EudraVigilance now lists 1,226,569 individual cases up to June 23 for the Pfizer-BioNTech vaccine tozinameran. Most are from Germany (217,974), followed by France (129,373), and the Netherlands (125,769).
A total 5,902 cases are listed for the Pfizer-BioNTech bivalent booster vaccine (tozinameran, riltozinameran) that targets the original strain of SARS-CoV-2, which is no longer circulating, and the Omicron BA.1 subvariant, which has been de-escalated by the European Centre for Disease Prevention and Control. Most cases are from the Netherlands (2,212), followed by Belgium (370), and Germany (238).
A total 8,693 cases are listed for the Pfizer-BioNTech bivalent booster vaccine (tozinameran, famtozinameran) that targets the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 subvariants. Most cases are from Germany (1,393), followed by Spain (1,086), and France (742).
A total 547,401 cases are listed for the AstraZeneca-Oxford vaccine with the most listed in Germany (54,774), followed by Austria (41,288), and the Netherlands (38,014).
A total 377,043 cases are listed for the Moderna vaccine (elasomeran). Most are from Germany (65,573), followed by the Netherlands (49,847), and France (34,306).
A total 7,777 cases are listed for the Moderna bivalent booster vaccine (elasomeran, imelasomeran) that targets the original strain of SARS-CoV-2 and the BA.1 subvariant. Most are from the Netherlands (3,594), followed by Spain (73), and France (56).
A total 596 cases are listed for the Moderna bivalent booster vaccine (elasomeran, davesomeran) that targets the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 subvariants. Twenty-two cases are listed for Germany, 19 for France, and 12 for Norway, along with ten cases in Ireland, eight in the Netherlands, seven in Italy, and five in Spain, but further data for individual countries is not provided.
A total 71,259 cases are listed for the Janssen Biotech vaccine. Most are from the Netherlands (15,095), followed by Germany with 12,126, and Austria (11,213).
A total 1,615 cases are now listed for the Novavax vaccine. Most are from Germany (1,002), followed by Italy with 158 cases, and France with 119.
A total 34 cases are listed for the Valneva vaccine. Seventeen cases are listed for Germany, 11 for Austria, and six for Italy.
A total 312 cases are reported for the VidPrevtyn Beta vaccine, developed by Sanofi Pasteur. Nine cases were reported in France, but the location of the other cases isn’t given.
There is more detail about these statistics on my Changing Times website along with data from other adverse event databases.
The World Health Organisation updates its VigiBase data every Sunday.
There was a new EudraVigilance update on June 26, which I report on here.
EudraVigilance doesn’t give a total of deaths reported after administration of each of the Covid-19 vaccines authorised for use in Europe, or a combined total. These figures can only be obtained by selecting reaction group categories, such cardiac disorders, and adding up all the individual totals.
See my June 23 Substack article for the latest VAERS data.